Integrated bioinformatics analysis of microarray data from non-small cell lung cancer.

Area of Science:

• Oncology
• Molecular Biology
• Bioinformatics

Background:

• Non-small cell lung cancer (NSCLC) presents significant challenges due to high mortality, lack of early diagnostic markers, and metastasis.
• Effective treatment strategies for NSCLC are limited, necessitating the identification of novel biomarkers and therapeutic targets.

Purpose of the Study:

• To identify potential microRNAs (miRNAs) and key genes in NSCLC for novel biomarker discovery and targeted gene therapies.
• To elucidate the regulatory networks underlying NSCLC pathogenesis.

Main Methods:

• Utilized Gene Expression Omnibus (GEO) datasets (GSE102286, GSE56036, etc.) to screen differentially expressed miRNAs (DE-miRNAs) and lncRNAs (DElncRs) using GEO2R and R.
• Performed pathway enrichment analysis, constructed protein-protein interaction (PPI) and competing endogenous RNA (ceRNA) networks using String, Funrich, and Cytoscape.
• Identified hub genes and miRNA-hub gene interactions.

Main Results:

• Screened nineteen co-expressed DE-miRNAs from five NSCLC datasets.
• Identified 7683 predicted DE-miRNA target genes significantly enriched in cancer-related pathways.
• Highlighted MYC, EGFR, HSP90AA1, TP53, and ACTB as top hub genes in the PPI network.
• Identified hsa-miR-21, hsa-miR-141, hsa-miR-200b, hsa-miR-30a, hsa-miR-30d, and hsa-miR-145 as key regulators of hub genes, with hsa-miR-141 and hsa-miR-145 prominent in regulatory networks.

Conclusions:

• The identified miRNAs, including hsa-miR-21, hsa-miR-141, hsa-miR-200b, hsa-miR-30a, hsa-miR-30d, and hsa-miR-145, provide a theoretical basis for understanding NSCLC development.
• These findings suggest potential novel biomarkers and therapeutic targets for NSCLC treatment.